Researchers show for the first time that human immune cells contain particles that have neurotransmitters including dopamine, which plays a crucial role in immune responses.
"These particles were previously thought to only exist in neurons in the brain and we think they are, potentially, an excellent target for therapies to speed up or dampen the body's immune response, depending on the disease you're dealing with," said the author.
Neurons rely on synaptic interactions and neurotransmitters such as dopamine, which are small molecules transmitted across synapses to deliver signals from one cell to another that play a major role in reward-motivated behavior.
Authors show that a proportion of human TFH cells contain dense-core granules marked by chromogranin B, which are normally found in neuronal presynaptic terminals storing catecholamines such as dopamine. TFH cells produce high amounts of dopamine and release it upon cognate interaction with B cells.
"Like neurons, specialised T cells transfer dopamine to B cells that provides additional 'motivation' for B cells to produce the best antibodies they can to help to clear up an infection," author said.
"The human body has developed an advanced form of protection against bacteria, viruses and other foreign bodies that relies on the immune system.
"Immune responses are essential for recognizing and defending humans against substances that appear foreign and harmful to the individual."
Dopamine causes rapid translocation of intracellular ICOSL (inducible T-cell co-stimulator ligand, also known as ICOSLG) to the B-cell surface, which enhances accumulation of CD40L and chromogranin B granules at the human TFHcell synapse and increases the synapse area.
The researchers analyzed around 200 tissue samples from children who had their tonsils removed, observing the transfer of dopamine from specialized T cells to B cells through a synaptic interaction.
They also worked with a mathematician to model the immune system's brain-like activity in a human in response to vaccines.
https://www.nature.com/nature/journal/vaop/ncurrent/full/nature23013.html
Latest News
A pair of brain regions pro…
By newseditor
Posted 09 Jun
How the gut microbiome resp…
By newseditor
Posted 08 Jun
Noncanonical cleavage mecha…
By newseditor
Posted 07 Jun
Reversing autoreactivity in…
By newseditor
Posted 07 Jun
Mapping metabolic fluxes in…
By newseditor
Posted 07 Jun
Other Top Stories
Commonly prescribed painkiller slows cancer growth
Read more
Protein puts the brakes on melanin
Read more
Mechanism that turns mutant cells into aggressive cancers
Read more
Promising treatment prospects for invasive breast cancer
Read more
Role of t-RNAs in driving metastatic cancer
Read more
Protocols
Hardwiring tissue-specific…
By newseditor
Posted 08 Jun
Using mass spectrometry ima…
By newseditor
Posted 07 Jun
Low-threshold, high-resolut…
By newseditor
Posted 05 Jun
Optical opening of the bloo…
By newseditor
Posted 04 Jun
Protocol to establish a gen…
By newseditor
Posted 03 Jun
Publications
Cancer-cell-derived fumarat…
By newseditor
Posted 09 Jun
Green light induces antinoc…
By newseditor
Posted 08 Jun
Arginine depletion attenuat…
By newseditor
Posted 08 Jun
Activity-dependent local pr…
By newseditor
Posted 08 Jun
The stress granule protein…
By newseditor
Posted 07 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar